Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 4,765-4,776 of 5,650
Behavioral study icon
RecruitingNCT06484075

Suvorexant for Addiction (AUD): Neural Mechanisms

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
AddictionBehavioralFrom 18 Years to 75 Years
Countries
United States
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition
Addiction
Drug study icon
RecruitingNCT06679062

Suvorexant for Treatment of AUD and PTSD

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Los Angeles
PTSD, AddictionDrugA study involving a medication or substance.From 21 Years to 65 Years
Countries
United States
Sponsor
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
Condition
PTSD, Addiction
Behavioral study icon
RecruitingNCT03995121

SV2 PET Imaging With [11C]APP311

This observational study is following people with Schizophrenia and Other psychosis, Addiction, or Healthy to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In New Haven
Schizophrenia, AddictionBehavioralFrom 18 Years to 85 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia, Addiction
Behavioral study icon
RecruitingNCT05472818

SV2A Density Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In New Haven
AddictionBehavioralFrom 18 Years to 75 Years
Countries
United States
Sponsor
Yale University
Condition
Addiction
Behavioral study icon
RecruitingNCT05996172

Swift Outpatient Alternatives for Rapid Stabilization

This summary needs review. Please check the official study record and contact the research team for details.

In Seattle
SuicidalityBehavioralFrom 13 Years to 21 Years
Countries
United States
Sponsor
University of Washington
Condition
Suicidality
Drug study icon
RecruitingNCT02639702

Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

In Toronto
SchizophreniaDrugOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT01627301

Sympathetic Overactivity in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Decatur
PTSDBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Emory University
Condition
PTSD
Behavioral study icon
RecruitingNCT06698588

Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms

This study is looking at whether a digital support tool can help people with Sleep, Autism or Autistic Traits, or ADHD or ADHD Traits. Participants take part in a digital support tool and complete follow-up assessments.

In Swansea
ADHDBehavioralFrom 5 Years to 12 Years
Countries
United Kingdom
Sponsor
Swansea University
Condition
ADHD
Behavioral study icon
RecruitingNCT07560878

Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

In Belmont
DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.